Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT.
Watabe T, Tatsumi M, Watabe H, Isohashi K, Kato H, Yanagawa M, Shimosegawa E, Hatazawa J.
Ann Nucl Med. 2012 Apr;26(3):222-7. doi: 10.1007/s12149-011-0562-3. Epub 2011 Dec 21.
Related citations
Radionuclide cardiac stress testing.
Badheka AO, Hendel RC.
Curr Opin Cardiol. 2011 Sep;26(5):370-8. Review.
Stress cardiac magnetic resonance.
Nabi F, Malaty A, Shah DJ.
Curr Opin Cardiol. 2011 Sep;26(5):385-91. Review.
Stress testing: the case for the standard treadmill test.
Miller TD.
Curr Opin Cardiol. 2011 Sep;26(5):363-9. Review.
Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study.
Sacher J, Rabiner EA, Clark M, Rusjan P, Soliman A, Boskovic R, Kish SJ, Wilson AA, Houle S, Meyer JH.
J Cereb Blood Flow Metab. 2012 Mar;32(3):443-6. doi: 10.1038/jcbfm.2011.184. Epub 2011 Dec 21.
Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship.
Kim E, Howes OD, Kim BH, Jeong JM, Lee JS, Jang IJ, Shin SG, Turkheimer FE, Kapur S, Kwon JS.
J Cereb Blood Flow Metab. 2012 Apr;32(4):759-68. doi: 10.1038/jcbfm.2011.180. Epub 2011 Dec 21.
Neurological picture. Increased muscle FDG-PET uptake in dermatomyositis.
Renard D, Chiper L, Collombier L, Labauge P.
J Neurol Neurosurg Psychiatry. 2012 May;83(5):487. Epub 2011 Dec 16. No abstract available.
4'-[Methyl-11C]-thiothymidine PET/CT for proliferation imaging in non-small cell lung cancer.
Minamimoto R, Toyohara J, Seike A, Ito H, Endo H, Morooka M, Nakajima K, Mitsumoto T, Ito K, Okasaki M, Ishiwata K, Kubota K.
J Nucl Med. 2012 Feb;53(2):199-206. Epub 2011 Dec 21.
Need for standardization of 18F-FDG PET/CT for treatment response assessments.
Boellaard R.
J Nucl Med. 2011 Dec;52 Suppl 2:93S-100S. Review.
Generating evidence for clinical benefit of PET/CT in diagnosing cancer patients.
Vach W, Høilund-Carlsen PF, Gerke O, Weber WA.
J Nucl Med. 2011 Dec;52 Suppl 2:77S-85S. Review.
Doing more harm than good? Do systematic reviews of PET by health technology assessment agencies provide an appraisal of the evidence that is closer to the truth than the primary data supporting its use?
Ware RE, Hicks RJ.
J Nucl Med. 2011 Dec;52 Suppl 2:64S-73S.
The Janus project: the remaking of nuclear medicine and radiology.
Larson SM.
J Nucl Med. 2011 Dec;52 Suppl 2:3S-9S. No abstract available.
How many PET tracers do we need?
Schwaiger M, Wester HJ.
J Nucl Med. 2011 Dec;52 Suppl 2:36S-41S.
Status of and trends in nuclear medicine in the United States.
Delbeke D, Segall GM.
J Nucl Med. 2011 Dec;52 Suppl 2:24S-8S.
Trends in nuclear medicine in developing countries.
Dondi M, Kashyap R, Paez D, Pascual T, Zaknun J, Bastos FM, Pynda Y.
J Nucl Med. 2011 Dec;52 Suppl 2:16S-23S.
Nuclear medicine at a crossroads.
Schelbert HR.
J Nucl Med. 2011 Dec;52 Suppl 2:10S-5S.
New pathways to medicare coverage for innovative PET radiopharmaceuticals: report of a medical imaging & technology alliance (MITA) workshop.
Hillman BJ, Frank RA, Rodriguez GM; Medical Imaging & Technology Alliance (MITA) Workshop participants.
J Nucl Med. 2012 Feb;53(2):336-42. Epub 2011 Dec 16.
An education opportunity for all: SNM's Mid-Winter Meeting.
Segall G.
J Nucl Med. 2011 Nov;52(11):33N. No abstract available.
Notification of proposed SNM Bylaws change.
Woolfenden JM.
J Nucl Med. 2011 Nov;52(11):30N-1N. No abstract available.
Gathering member feedback on SNM name change.
Anderson CJ.
J Nucl Med. 2011 Nov;52(11):29N-30N. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on